523 related articles for article (PubMed ID: 15999048)
21. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
[TBL] [Abstract][Full Text] [Related]
22. The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy.
Levy JH; Montes F; Szlam F; Hillyer CD
Anesth Analg; 2000 May; 90(5):1076-9. PubMed ID: 10781455
[TBL] [Abstract][Full Text] [Related]
23. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
Brister SJ; Ofosu FA; Buchanan MR
Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
[TBL] [Abstract][Full Text] [Related]
24. Heparin management during cardiac surgery with respect to various blood-conservation techniques.
Boldt J; Zickmann B; Herold C; Scholz S; Dapper F; Hempelmann G
Surgery; 1992 Mar; 111(3):260-5. PubMed ID: 1542853
[TBL] [Abstract][Full Text] [Related]
25. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
[TBL] [Abstract][Full Text] [Related]
26. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
[TBL] [Abstract][Full Text] [Related]
27. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
[TBL] [Abstract][Full Text] [Related]
28. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
29. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
[TBL] [Abstract][Full Text] [Related]
30. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
[TBL] [Abstract][Full Text] [Related]
31. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study.
Levy JH; Despotis GJ; Szlam F; Olson P; Meeker D; Weisinger A
Anesthesiology; 2002 May; 96(5):1095-102. PubMed ID: 11981148
[TBL] [Abstract][Full Text] [Related]
33. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
34. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
[TBL] [Abstract][Full Text] [Related]
35. Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding.
Suehiro S; Shibata T; Sasaki Y; Hattori K; Kumano H; Hosono M; Kinoshita H
Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):225-9. PubMed ID: 10508946
[TBL] [Abstract][Full Text] [Related]
36. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study.
Abdel-Rahman U; Martens S; Risteski P; Ozaslan F; Riaz M; Moritz A; Wimmer-Greinecker G
Heart Surg Forum; 2006; 9(1):E543-8. PubMed ID: 16403712
[TBL] [Abstract][Full Text] [Related]
37. Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery.
Bar-Yosef S; Cozart HB; Phillips-Bute B; Mathew JP; Grocott HP
Can J Anaesth; 2007 Feb; 54(2):107-13. PubMed ID: 17272249
[TBL] [Abstract][Full Text] [Related]
38. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates.
Niebler RA; Woods KJ; Murkowski K; Ghanayem NS; Hoffman G; Mitchell ME; Punzalan RC; Scott JP; Simpson P; Tweddell JS
Artif Organs; 2016 Jan; 40(1):80-5. PubMed ID: 26620919
[TBL] [Abstract][Full Text] [Related]
39. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
[TBL] [Abstract][Full Text] [Related]
40. Gabexate mesilate and heparin responsiveness in coronary patients.
Ranucci M
Med Sci Monit; 2004 Mar; 10(3):PI40-3. PubMed ID: 14976449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
